Consequently, the objective of this study was to assess NRP2 and its ligand SEMA3F as potential biomarkers for patient survival and their ability to predict lymph node metastases in esophageal adenocarcinoma. This evidence concerns the gene NRP2 and esophageal adenocarcinoma.